|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q112692814
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000238.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q112692814
|
|
035
|
|
|
‡a
(OCoLC)Q112692814
|
|
100
|
0 |
|
‡a
Donghui Li
‡c
researcher
‡9
en
|
|
670
|
|
|
‡a
Author's 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer
|
|
670
|
|
|
‡a
Author's ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer
|
|
670
|
|
|
‡a
Author's Association between hepatitis B virus and pancreatic cancer
|
|
670
|
|
|
‡a
Author's Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States
|
|
670
|
|
|
‡a
Author's Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.
|
|
670
|
|
|
‡a
Author's Association of diabetes and perineural invasion in pancreatic cancer.
|
|
670
|
|
|
‡a
Author's Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's Association of multi‐drug resistance gene polymorphisms with pancreatic cancer outcome
|
|
670
|
|
|
‡a
Author's AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.
|
|
670
|
|
|
‡a
Author's Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer
|
|
670
|
|
|
‡a
Author's Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
|
|
670
|
|
|
‡a
Author's Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
|
|
670
|
|
|
‡a
Author's Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.
|
|
670
|
|
|
‡a
Author's Diagnostic protein discovery using proteolytic peptide targeting and identification
|
|
670
|
|
|
‡a
Author's Dietary mutagen exposure and risk of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery
|
|
670
|
|
|
‡a
Author's DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer
|
|
670
|
|
|
‡a
Author's DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer
|
|
670
|
|
|
‡a
Author's DNA repair gene polymorphisms and risk of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study
|
|
670
|
|
|
‡a
Author's Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Effects of base excision repair gene polymorphisms on pancreatic cancer survival
|
|
670
|
|
|
‡a
Author's Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
|
|
670
|
|
|
‡a
Author's Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction
|
|
670
|
|
|
‡a
Author's Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer
|
|
670
|
|
|
‡a
Author's Glucose metabolism gene variants modulate the risk of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer
|
|
670
|
|
|
‡a
Author's Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer
|
|
670
|
|
|
‡a
Author's K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking
|
|
670
|
|
|
‡a
Author's Metformin use is associated with better survival of diabetic patients with pancreatic cancer
|
|
670
|
|
|
‡a
Author's New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts
|
|
670
|
|
|
‡a
Author's Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study
|
|
670
|
|
|
‡a
Author's Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins
|
|
670
|
|
|
‡a
Author's Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes
|
|
670
|
|
|
‡a
Author's Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
|
|
670
|
|
|
‡a
Author's RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.
|
|
670
|
|
|
‡a
Author's Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus
|
|
670
|
|
|
‡a
Author's Risk factors for pancreatic cancer: case-control study
|
|
670
|
|
|
‡a
Author's Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.
|
|
670
|
|
|
‡a
Author's Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer.
|
|
670
|
|
|
‡a
Author's Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer
|
|
670
|
|
|
‡a
Author's Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival
|
|
670
|
|
|
‡a
Author's Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer
|
|
670
|
|
|
‡a
Author's Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity
|
|
670
|
|
|
‡a
Author's Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer
|
|
670
|
|
|
‡a
Author's The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States
|
|
670
|
|
|
‡a
Author's The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells
|
|
670
|
|
|
‡a
Author's The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation
|
|
670
|
|
|
‡a
Author's The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk
|
|
670
|
|
|
‡a
Author's XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer
|
|
919
|
|
|
‡a
riskfactorsforhepatocellularcarcinomasynergismofalcoholwithviralhepatitisanddiabetesmellitus
‡A
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
recq1a159cpolymorphismisassociatedwithoverallsurvivalofpatientswithresectedpancreaticcancerareplicationstudyinnrgoncologyradiationtherapyoncologygroup
‡A
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.
‡9
1
|
|
919
|
|
|
‡a
proteinexpressionprofilesinpancreaticadenocarcinomacomparedwithnormalpancreatictissueandtissueaffectedbypancreatitisasdetectedby2dimensionalgelelectrophoresisandmassspectrometry
‡A
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
‡9
1
|
|
919
|
|
|
‡a
polymorphismsofphase2xenobioticmetabolizinganddnarepairgenesandinvitronethylnnitrosoureainducedo6ethylguaninelevelsinhumanlymphocytes
‡A
Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes
‡9
1
|
|
919
|
|
|
‡a
plasmaproteinprofilingfordiagnosisofpancreaticcancerrevealsthepresenceofhostresponseproteins
‡A
Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins
‡9
1
|
|
919
|
|
|
‡a
passivesmokingandtheuseofnoncigarettetobaccoproductsinassociationwithriskforpancreaticcanceracasecontrolstudy
‡A
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study
‡9
1
|
|
919
|
|
|
‡a
newstrategiesinpancreaticcanceremergingepidemiologicandtherapeuticconcepts
‡A
New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts
‡9
1
|
|
919
|
|
|
‡a
metforminuseisassociatedwithbettersurvivalofdiabeticpatientswithpancreaticcancer
‡A
Metformin use is associated with better survival of diabetic patients with pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
krasmutationandp16andpreproenkephalinpromoterhypermethylationinplasmadnaofpancreaticcancerpatientsinrelationtocigarettesmoking
‡A
K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking
‡9
1
|
|
919
|
|
|
‡a
insulinlikegrowthfactoraxisgenepolymorphismsmodifyriskofpancreaticcancer
‡A
Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
insulinlikegrowthfactoraxisgenepolymorphismsandclinicaloutcomesinpancreaticcancer
‡A
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
impactsofnewonsetandlongtermdiabetesonclinicaloutcomeofpancreaticcancer
‡A
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
glutathionestransferasegenepolymorphismsandriskandsurvivalofpancreaticcancer
‡A
Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
glucosemetabolismgenevariantsmodulatetheriskofpancreaticcancer
‡A
Glucose metabolism gene variants modulate the risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
glucosemetabolismgenepolymorphismsandclinicaloutcomeinpancreaticcancer
‡A
Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
geneticvariationinthepnpla3geneandhepatocellularcarcinomainusariskandprognosisprediction
‡A
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction
‡9
1
|
|
919
|
|
|
‡a
gemcitabinemetabolicandtransportergenepolymorphismsareassociatedwithdrugtoxicityandefficacyinpatientswithlocallyadvancedpancreaticcancer
‡A
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
effectsofbaseexcisionrepairgenepolymorphismsonpancreaticcancersurvival
‡A
Effects of base excision repair gene polymorphisms on pancreatic cancer survival
‡9
1
|
|
919
|
|
|
‡a
effectofinsulinlikegrowthfactorgenepolymorphismsaloneorininteractionwithdiabetesontheriskofpancreaticcancer
‡A
Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
effectofdifferenttypesofsmokingandsynergismwithhepatitis100virusonriskofhepatocellularcarcinomainamericanmenandwomencasecontrolstudy
‡A
Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study
‡9
1
|
|
919
|
|
|
‡a
dnarepairgenepolymorphismsandriskofpancreaticcancer
‡A
DNA repair gene polymorphisms and risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
dnamismatchrepairnetworkgenepolymorphismasasusceptibilityfactorforpancreaticcancer
‡A
DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
dnamismatchrepairgenepolymorphismsaffectsurvivalinpancreaticcancer
‡A
DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
directtandemmassspectrometryrevealslimitationsinproteinprofilingexperimentsforplasmabiomarkerdiscovery
‡A
Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery
‡9
1
|
|
919
|
|
|
‡a
dietarymutagenexposureandriskofpancreaticcancer
‡A
Dietary mutagen exposure and risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
diagnosticproteindiscoveryusingproteolyticpeptidetargetingandidentification
‡A
Diagnostic protein discovery using proteolytic peptide targeting and identification
‡9
1
|
|
919
|
|
|
‡a
diagnosticproteindiscoveryusingliquidchromatographymassspectrometryforproteolyticpeptidetargeting
‡A
Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.
‡9
1
|
|
919
|
|
|
‡a
diabetespancreatogenicdiabetesandpancreaticcancer
‡A
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
‡9
1
|
|
919
|
|
|
‡a
bodymassindexandriskageofonsetandsurvivalinpatientswithpancreaticcancer
‡A
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
bodymassindexandobesityanddiabetesassociatedgenotypesandriskforpancreaticcancer
‡A
Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
aurkaamplificationchromosomeinstabilityandcentrosomeabnormalityinhumanpancreaticcarcinomacells
‡A
AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.
‡9
1
|
|
919
|
|
|
‡a
associationofmultidrugresistancegenepolymorphismswithpancreaticcanceroutcome
‡A
Association of multi‐drug resistance gene polymorphisms with pancreatic cancer outcome
‡9
1
|
|
919
|
|
|
‡a
associationofdiabetesdurationanddiabetestreatmentwiththeriskofhepatocellularcarcinoma
‡A
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
‡9
1
|
|
919
|
|
|
‡a
associationofdiabetesandperineuralinvasioninpancreaticcancer
‡A
Association of diabetes and perineural invasion in pancreatic cancer.
‡9
1
|
|
919
|
|
|
‡a
associationofchfrpromotermethylationwithdiseaserecurrenceinlocallyadvancedcoloncancer
‡A
Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.
‡9
1
|
|
919
|
|
|
‡a
associationbetweenhypothyroidismandhepatocellularcarcinomaacasecontrolstudyintheunitedstates
‡A
Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States
‡9
1
|
|
919
|
|
|
‡a
associationbetweenhepatitisbvirusandpancreaticcancer
‡A
Association between hepatitis B virus and pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
abononotypeasariskfactorforthrombosisinpatientswithpancreaticcancer
‡A
ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
510methylenetetrahydrofolatereductasepolymorphismsandtheriskofpancreaticcancer
‡A
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
xrcc2andxrcc3genepolymorphismandriskofpancreaticcancer
‡A
XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
xpdasp312asnandlys751glnpolymorphismscorrespondinghaplotypeandpancreaticcancerrisk
‡A
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk
‡9
1
|
|
919
|
|
|
‡a
rapamycinanalog201779isapotentinhibitorofpancreaticcancercellproliferation
‡A
The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation
‡9
1
|
|
919
|
|
|
‡a
pi3kinaseaktsignalingpathwayisactivatedduetoaberrantptenexpressionandtargetstranscriptionfactorsnfkappaband100mycinpancreaticcancercells
‡A
The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells
‡9
1
|
|
919
|
|
|
‡a
associationoffamilyhistoryoflivercancerwithhepatocellularcarcinomaacasecontrolstudyintheunitedstates
‡A
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States
‡9
1
|
|
919
|
|
|
‡a
singlenucleotidepolymorphismsofrecq1rad54landatmgenesareassociatedwithreducedsurvivalofpancreaticcancer
‡A
Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
singlenucleotidepolymorphismsofgemcitabinemetabolicgenesandpancreaticcancersurvivalanddrugtoxicity
‡A
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity
‡9
1
|
|
919
|
|
|
‡a
singlenucleotidepolymorphismsofdnadamageresponsegenesareassociatedwithoverallsurvivalinpatientswithpancreaticcancer
‡A
Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
significanteffectofhomologousrecombinationdnarepairgenepolymorphismsonpancreaticcancersurvival
‡A
Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival
‡9
1
|
|
919
|
|
|
‡a
significantassociationsofmismatchrepairgenepolymorphismswithclinicaloutcomeofpancreaticcancer
‡A
Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
serumamyloidaasatumormarkerinseraofnudemicewithorthotopichumanpancreaticcancerandinplasmaofpatientswithpancreaticcancer
‡A
Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer.
‡9
1
|
|
919
|
|
|
‡a
selectedpolymorphismsofdnarepairgenesandriskofpancreaticcancer
‡A
Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.
‡9
1
|
|
919
|
|
|
‡a
riskfactorsforpancreaticcancercasecontrolstudy
‡A
Risk factors for pancreatic cancer: case-control study
‡9
1
|
|
996
|
|
|
‡2
DNB|171901134
|
|
996
|
|
|
‡2
NTA|325854025
|
|
996
|
|
|
‡2
NTA|39346458X
|
|
996
|
|
|
‡2
DNB|1300656433
|
|
996
|
|
|
‡2
DNB|1324573627
|
|
996
|
|
|
‡2
J9U|987007357746405171
|
|
996
|
|
|
‡2
LC|nb2012008837
|
|
996
|
|
|
‡2
ISNI|0000000367621031
|
|
996
|
|
|
‡2
LC|n 2012017841
|
|
996
|
|
|
‡2
DNB|1036651924
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Donghui Li
‡c
researcher
‡2
WKP|Q87993608
‡3
duplicate
|
